Discovery Diabetes: A Pilot Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main questions it aims to answer are: Does the Discovery Program lead to better glycemic control as measured by HbA1c levels? How does participation in the Discovery Program affect diabetes distress and self-management skills? Researchers will compare participants in the Discovery Program to those receiving standard diabetes care to see if the program has a positive effect on diabetes management. Participants will: Engage in a 3-month intervention that includes personalized mobile health communications and clinician support. Complete surveys and assessments at the beginning of the study, and again at 3 and 6 months. Allow the study team to access their electronic health records for additional data on diabetes management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 21
Healthy Volunteers: f
View:

• Adolescents (13-17 years) and young adults (aged 18-21 years),

• Diagnosed with T1D for at least one year,

• Access to a smartphone,

• A My Health at Vanderbilt (MHAV) patient portal account,

• Ability to read, speak, and understand English,

• An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact

Locations
United States
Tennessee
Vanderbilt University
RECRUITING
Nashville
Contact Information
Primary
Abigail Doyle, MSHI
abigail.m.doyle@vanderbilt.edu
615-343-6075
Backup
Dina Bu, BS
dina.bu@vumc.org
Time Frame
Start Date: 2025-11
Estimated Completion Date: 2027-11
Participants
Target number of participants: 150
Treatments
Experimental: Intervention Group: Discovery Program
This arm will receive the Discovery Program intervention, which includes personalized mobile health communications and clinician support aimed at improving diabetes management.
No_intervention: Control Group: Standard Diabetes Care
This arm will continue with standard diabetes care practices without the additional psychosocial intervention provided to the intervention group.
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University Medical Center

This content was sourced from clinicaltrials.gov